Cutaneous Cancer Biology

Area of Science:

• Dermatology and Oncology
• Molecular Biology
• Cancer Research

Background:

• Global incidence of nonmelanoma skin cancer (NMSC), including squamous cell carcinoma, basal cell carcinoma, and melanoma, is increasing.
• While most skin cancers are surgically treatable, advanced cases (fewer than 10%) necessitate further therapeutic interventions.
• Enhanced understanding of skin cancer biology is crucial for improved prognostication and the discovery of novel therapeutic targets.

Purpose of the Study:

• To review the fundamental biology and pathogenesis of NMSC and melanoma.
• To highlight critical cell signaling pathways involved in skin cancer development.
• To discuss current therapeutic strategies targeting specific genetic pathways in skin cancer.

Main Methods:

• Literature review of scientific articles on skin cancer biology and treatment.
• Analysis of key cell signaling pathways implicated in NMSC and melanoma.
• Synthesis of information on current and emerging therapeutic strategies.

Main Results:

• Detailed overview of the molecular mechanisms driving NMSC and melanoma.
• Identification of critical signaling pathways (e.g., Wnt, Hedgehog, MAPK) in skin carcinogenesis.
• Summary of targeted therapies based on genetic mutations and pathway dysregulation.

Conclusions:

• A comprehensive understanding of skin cancer biology is essential for advancing patient care.
• Targeted therapies focusing on specific molecular pathways offer promising treatment avenues for advanced NMSC and melanoma.
• Further research into skin cancer pathogenesis will likely yield new prognostic markers and therapeutic targets.